Approvals/TGA/TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe

Approved

STANDARD

TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e2548412e02522da
Product Name: TAKHZYRO lanadelumab 300 mg/2 mL solution for injection pre-filled syringe
Artg Id: 330280
Artg Name: TAKHZYRO lanadelumab (rch) 300 mg/2 mL solution for injection pre-filled syringe
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2020-06-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-02062-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01119-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e2548412e02522da

Type

Standard